Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anorexia-cachexia Syndrome
Study findings on anorexia-cachexia syndrome are outlined in reports from Kagoshima University
January 13th, 2009
"The cancer-associated anorexia-cachexia syndrome is observed in 80% of patients with advanced-stage cancer, and is one of the major obstacles in chemotherapy," researchers in Kagoshima, Japan report. "Ghrelin is a orexigenic hormone that has been proposed to prevent anorexia," wrote S. Perboni and colleagues, Kagoshima University. The researchers concluded: "Aim of the study was to determine whether the addition of the ghrelin agonist growth hormone releasing peptide 2 (GHRP-2) to cytotoxic therapy with 5-fluoruracil (5-FU) prevents the anorexia associated with chemotherapy in cancer cachectic mice." Perboni and colleagues...
Source: Cancer Weekly (2009-01-13)
|
